Skip to main content
Log in

Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Intergroup 0116 (Southwest Oncology Group 9008), a national, multicenter, two-armed, prospective, randomized trial of adjuvant postoperative chemoradiotherapy, has demonstrated significant benefit.

Methods

We prospectively captured complete surgical information, including the treatment of various lymph node stations, for 553 of the 556 eligible participants in this trial. Before any survival analysis, we coded D level by using the Japanese general rules and used the Maruyama program to estimate the likelihood of disease in undissected regional node stations, defining the sum of these estimates as the Maruyama Index of Unresected Disease (MI). We analyzed survival with Cox multivariate regression.

Results

Fifty-four percent of participating patients underwent D0 lymphadenectomy. The median MI was 70 (range, 0–429). In contrast to D level, MI proved to be an independent prognostic factor, even with adjustment for the potentially linked variables of T stage and number of positive nodes. We detected no significant interaction between surgical or pathologic variables and the favorable effect of adjuvant treatment, but the power to detect such interaction was generally low.

Conclusions

MI, a measure of unresected regional nodal disease in gastric cancer, proved an independent predictor of survival. Surgical undertreatment, as observed in this trial, clearly undermined survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics.CA Cancer J Clin 1999;49:33–64.

    PubMed  CAS  Google Scholar 

  2. Greenlee RT, Hill-Harmon MB, Taylor M, Thun M. Cancer statistics, 2001.CA Cancer J Clin 2001;51:15–36.

    Article  PubMed  CAS  Google Scholar 

  3. Moertel CG, Childs DS Jr, Reitemeier RJ, Colby MY. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.Lancet 1969;2:865–7.

    Article  PubMed  CAS  Google Scholar 

  4. Gastrointestinal Tumor Study Group. A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma.Cancer 1982;49:1771–7.

    Article  Google Scholar 

  5. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the somach or gastroesophageal junction.N Engl J Med 2001; 345:725–30.

    Article  PubMed  CAS  Google Scholar 

  6. American Joint Committee on Cancer.Manual for Staging of Cancer, 3rd ed., Philadelphia: Lippincott, 1988.

    Google Scholar 

  7. Nishi M, Omori Y, Miwa K, eds.Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara & Co Ltd, 1995.

    Google Scholar 

  8. Kampschoer GHM, Maruyama K, Van de Velde CJH, Sasako M, Kinoshita T, Okabayashi K. Computer analysis in making preopcrative decisions: a rational approach to lymph node dissection in gastric cancer patients.Br J Surg 1989;76:905–8.

    Article  PubMed  CAS  Google Scholar 

  9. Bollschweiler E, Boettcher K, Hoelscher AH, et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program.Br J Surg 1992;79:156–60.

    Article  PubMed  CAS  Google Scholar 

  10. American Joint Committee on Cancer.Manual for Staging of Cancer. 5th ed. Philadelphia: Lippincott, 1997.

    Google Scholar 

  11. Cox DR. Regression models and life tables.J R Stat Soc B 1972;34:187–220.

    Google Scholar 

  12. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on Cancer staging, proximal disease, and the ‘different disease’ hypothesis.Cancer 2000;88:921–32.

    Article  PubMed  CAS  Google Scholar 

  13. Estes NC, Macdonald JS, Touijer K, Benedetti J, Jacobson J. Inadequate documentation and resection for gastric cancer in the United States: a preliminary report.Am Surg 1998;64:680–5.

    PubMed  CAS  Google Scholar 

  14. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R. Cancer of the stomach—a patient care evaluation study by the American College of Surgeons.Ann Surg 1993;218:583–92.

    Article  PubMed  CAS  Google Scholar 

  15. Wanebo HJ, Kennedy BJ, Winchester DP, Fremgen A, Stewart AK. Gastric carcinoma: does lymph node dissection alter survival?J Am Coll Surg 1996;183:616–24.

    PubMed  CAS  Google Scholar 

  16. Brennan MF. Radical surgery for gastric cancer. A review of the Japanese experience.Cancer 1989;64:2063.

    Article  PubMed  CAS  Google Scholar 

  17. Fielding JWL. Gastric cancer: different diseases.Br J Surg 1989; 76:1227.

    Article  PubMed  CAS  Google Scholar 

  18. Douglas HO. R2 dissection in the treatment of gastric malignancy.Surg Oncol Clin North Am 1993;2:413–31.

    Google Scholar 

  19. Dent DM, Madden MV, Price SK. Randomized comparison of R-1 and R-2 gastrectomy for gastric carcinoma.Surg Oncol Clin North Am 1993;2:433–41.

    Google Scholar 

  20. Hundahl SA. Gastric cancer nodal metastases: biologic significance and therapeutic considerations.Surg Oncol Clin North Am 1996;5:129–44.

    CAS  Google Scholar 

  21. Bonenkamp JJ, Hermans J, Sasako M, Van de Velde CJH. Extended lymph nodded dissection for gastric cancer.N Engl J Med 1999;340:908–14.

    Article  PubMed  CAS  Google Scholar 

  22. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D-1 and D-2 resections for gastric cancer: long-term results of the MRC randomized surgical trial.Br J Cancer 1999;79:1522–30

    Article  PubMed  CAS  Google Scholar 

  23. Robertson CS, Chung SCS, Woods SDS, et al. A prospective randomized trial comparing R-1 subtotal gastrectomy with R-3 total gastrectomy for antral cancer.Ann Surg 1994;220:176–82.

    Article  PubMed  CAS  Google Scholar 

  24. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter, randomized Italian trial.Ann Surg 1999;230:170–8.

    Article  PubMed  CAS  Google Scholar 

  25. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial.Br J Surg 1997;84:1567–71.

    Article  PubMed  CAS  Google Scholar 

  26. Bonenkamp JJ, Songun I, Hermans J, et al. Randomized comparison of morbidity after D1 and D2 dissections for gastric cancer in 996 Dutch patients.Lancet 1995;345:745–8.

    Article  PubMed  CAS  Google Scholar 

  27. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial.Lancet 1996;347:995–9.

    Article  PubMed  CAS  Google Scholar 

  28. Brennan MF. Lymph node dissection for gastric cancer.N Engl J Med 1999;340:956–8.

    Article  PubMed  CAS  Google Scholar 

  29. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques are a source of misleading statistics for survival in cancer.N Engl J Med 1985; 312:1604–8.

    Article  PubMed  CAS  Google Scholar 

  30. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer.World J Surg 1995;19:532–6.

    Article  PubMed  CAS  Google Scholar 

  31. McCulloch P. Should general surgeons treat gastric carcinoma? An audit of practice and results, 1980–1985.Br J Surg 1994;81:417–20.

    Article  PubMed  CAS  Google Scholar 

  32. Siewert JR, Kelsen D, Maruyama K, et al.Gastric Cancer Diagnosis and Treatment—An Interactive Training Program. Version 1.0. CD-ROM. Heidelberg: Springer Electronic Media, 2000.

    Google Scholar 

  33. Cady B. Fundamentals of contemporary surgical oncology: biologie principles and the threshold concept govern treatment and outcomes.J Am Coll Surg 2001;192:777–92.

    Article  PubMed  CAS  Google Scholar 

  34. Kelsen DP. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 0116.J Clin Oncol 2000;18(21 Suppl):32S-34S.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Scott A. Hundahl MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hundahl, S.A., Macdonald, J.S., Benedetti, J. et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Annals of Surgical Oncology 9, 278–286 (2002). https://doi.org/10.1007/BF02573066

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02573066

Key Words

Navigation